Table 2.
Characteristic | Total Registered Patients At The Hospital (n=268) | Patients Interviewed At The Hospital (n=202) | Patients Interviewed At Their Home (n=111) |
---|---|---|---|
n (%) | n (%) | n (%) | |
Gender | |||
Female | 83 (31.0) | 67 (33.2) | 34 (30.6) |
Male | 185 (69.0) | 135 (66.8) | 77 (69.4) |
Age (Median, IQR) | 37 (27, 49) | 36 (26, 48) | 38 (27, 48) |
Ethnic group | |||
Han | 199 (74.3) | 140 (69.3) | 83 (74.8) |
Other | 69 (25.7) | 62 (30.7) | 28 (25.2) |
Occupation before MDR-TB | |||
Migrant worker | 55 (20.5) | 52 (25.7) | 26 (23.4) |
Farmer | 103 (38.4) | 61 (30.2) | 40 (36.0) |
Government worker | 15 (5.6) | 15 (7.4) | 5 (4.5) |
Company worker | 37 (13.8) | 37 (18.3) | 17 (15.3) |
Student | 26 (9.7) | 26 (12.9) | 16 (14.4) |
Unemployed | 32 (11.9) | 11 (5.4) | 7 (6.3) |
Area of residence | |||
Urban | 46 (17.2) | 41 (20.3) | 19 (17.1) |
Rural | 222 (82.8) | 161 (79.7) | 92 (82.9) |
Classification of MDR-TB | |||
Primary | 24 (9.0) | 21 (10.4) | 11 (9.9) |
Secondary | 244 (91.0) | 181 (89.6) | 100 (90.1) |
Duration of treatment (months) | |||
<12 | 76 (28.4) | 60 (29.7) | 35 (31.5) |
12–24 | 192 (71.6) | 142 (70.3) | 76 (68.5) |
Marital status | |||
Single | – | 78 (38.6) | 38 (34.2) |
Married | – | 124 (61.4) | 73 (65.8) |
Education level | |||
Primary school or less | – | 60 (29.7) | 39 (35.1) |
Middle school | – | 68 (33.7) | 30 (27.0) |
High school | – | 55 (27.2) | 35 (31.5) |
University | – | 19 (9.4) | 7 (6.3) |
Occupational status after getting MDR-TB | |||
Still working | – | 62 (30.7) | 31 (27.9) |
Lost job or could not work | – | 103 (51.0) | 57 (51.4) |
Student/unemployed | – | 37 (18.3) | 23 (20.7) |
Per capita annual income (Median, IQR) | – | 1761 (1172, 3258) | 1574 (1003, 3168) |
Insurance scheme | |||
UEBMI | – | 22 (10.9) | 8 (7.2) |
URBMI | – | 6 (3.0) | 4 (3.6) |
NRCMS | – | 169 (83.7) | 99 (89.2) |
None | 5 (2.5) | 0 | |
Monthly drug costs before reimbursement (Mean, SD) | – | 240.6, 160.2 | 245.4, 166.6 |
Monthly OOP of drug costs (Mean, SD) | – | 149.5, 157.3 | 152.6, 166.2 |
In debt due to MDR-TB | – | 120 (59.4) | 66 (59.5) |
Received DOT | – | 56 (27.7) | 30 (27.0) |
Baseline co-morbidity | – | 40 (19.8) | 27 (24.3) |
DM | – | 18 (8.9) | 12 (10.8) |
Hepatitis B | – | 6 (3.0) | 3 (2.7) |
COPD | – | 5 (2.5) | 4 (3.6) |
Othersa | – | 11(5.4) | 8 (7.2) |
Notes: All costs are in United States dollars. Column 2 is a subgroup of column 1, and column 3 is a subgroup of column 2. aOthers: in group 2, 11 patients included gastritis (n=3), uarthritis (n=3), hypertension (n=2), hyperuricemia (n=2), coronary heart disease (n=1). In group 3, 8 patients included gastritis (n=2), uarthritis (n=2), hypertension (n=1), hyperuricemia (n=2), coronary heart disease (n=1).
Abbreviations: DOT, directly observed treatment; IQR, interquartile range; SD, standard deviation; MDR-TB, multidrug-resistant tuberculosis; NRCMS, New Rural Cooperative Medical Scheme; OOP, out-of-pocket; UEBMI, Urban Employee Basic Medical Insurance; URBMI, Urban Resident Basic Medical Insurance; DM, diabetes; COPD, chronic obstructive pulmonary disease.